Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 1
1994 1
1996 1
1997 1
2001 1
2002 3
2003 2
2004 6
2005 7
2006 7
2007 5
2008 2
2009 2
2010 3
2011 2
2012 8
2013 6
2014 5
2015 7
2016 4
2017 4
2018 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15709124

77 results
Results by year
Filters applied: . Clear all
Page 1
Differential chemosensitivity of tumor components in a malignant oligodendroglioma: assessment with diffusion-weighted, perfusion-weighted, and serial volumetric MR imaging.
Jäger HR, Waldman AD, Benton C, Fox N, Rees J. Jäger HR, et al. AJNR Am J Neuroradiol. 2005 Feb;26(2):274-8. AJNR Am J Neuroradiol. 2005. PMID: 15709124 Free article.
Application of diffusion-weighted imaging and dynamic susceptibility contrast perfusion-weighted imaging for ganglioglioma in adults: Comparison study with oligodendroglioma.
Lee S, Yun TJ, Kang KM, Rhim JH, Park CK, Kim TM, Park SH, Kim IH, Choi SH. Lee S, et al. J Neuroradiol. 2016 Oct;43(5):331-8. doi: 10.1016/j.neurad.2016.06.001. Epub 2016 Aug 5. J Neuroradiol. 2016. PMID: 27502573
Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM, Kros JM, de Bruin HG, Enting RH, van Heuvel I, Looijenga LH, van der Rijt CD, Smitt PA, van den Bent MJ. Stege EM, et al. Cancer. 2005 Feb 15;103(4):802-9. doi: 10.1002/cncr.20828. Cancer. 2005. PMID: 15637687 Free article.
Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R. Buckner JC, et al. J Clin Oncol. 2003 Jan 15;21(2):251-5. doi: 10.1200/JCO.2003.06.023. J Clin Oncol. 2003. PMID: 12525516 Clinical Trial.
Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M, Saueressig U, van Buiren M, Kontny U, Niemeyer C, Köhler G, Ilyasov K, Langer M. Uhl M, et al. Invest Radiol. 2006 Aug;41(8):618-23. doi: 10.1097/01.rli.0000225398.17315.68. Invest Radiol. 2006. PMID: 16829744
Diffusion-weighted MR imaging for the regional characterization of liver tumors.
Wagner M, Doblas S, Daire JL, Paradis V, Haddad N, Leitão H, Garteiser P, Vilgrain V, Sinkus R, Van Beers BE. Wagner M, et al. Radiology. 2012 Aug;264(2):464-72. doi: 10.1148/radiol.12111530. Epub 2012 Jun 12. Radiology. 2012. PMID: 22692032
77 results
Jump to page
Feedback